The Global Extracorporeal Membrane Oxygenation (ECMO) Market Report offers details on current and future growth trends pertaining to the business besides information on numerous regions across the geographical landscape of the Extracorporeal Membrane Oxygenation (ECMO) Market. The study includes global, regional, and country-level market size, shares, growth rate analysis (include the causes of highest and lowest peak industry analysis), product launches, latest trends, the impact of covid19 on worldwide.
Extracorporeal Membrane
Oxygenation (ECMO) Market Research Methodology overview consists of primary and
secondary research, company share analysis, model (including Demographic data,
Macroeconomic indicators, and Industry indicators i.e. Expenditure,
infrastructure, sector growth, and facilities, etc), Research Limitations, and
Revenue Based Modelling. Comprehensive analysis of Extracorporeal Membrane
Oxygenation (ECMO) Market based on current & future analysis depending on
historic data also featured in this Report.
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures, Chart and Covid-19 Impact Analysis) @ https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market/request-sample
Industry Insights
The global Extracorporeal
Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016
and is expected to grow at CAGR of 4.3% over the forecast period. The major
factors boosting growth are the rising incidences of Chronic Obstructive
Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases
and respiratory failures.
According to data recorded
by the American Lung Association (ALA), in 2013, COPD was recorded to be the
third largest cause of death across the U.S. In addition, over 24.0 million
individuals are estimated to remain undiagnosed in the U.S. and 11.0 million
diagnosed for COPD.
Also, the increasing
adoption of unhealthy lifestyles, such as rise in the total tobacco consumption
level among both, females and males and further development of lifestyle
disorders are augmenting the incidence rate of COPD. ECMO machines are gaining
popularity in the hospital and healthcare systems due to the rising trend of
its application during cases of respiratory disorders.
The ECMO machines are used
in cases of cardiac failure to facilitate auxiliary oxygen support system.
These machines are frequently used in patients suffering from respiratory
conditions and also in neonates and pediatric patients. The estimated growth of
these machines can be attributed to the critical nature of the target
population consisting of neonates and pediatric patients.
Modality Insights
The segmentation of the key
modalities is done on the basis of the different setups that are provided by
the ECMO circuit such as arterio-venous, veno-arterial and veno-venous. They
are used to provide hemodynamic support and to facilitate gaseous exchange in
patients with cardiac or respiratory failure.
Both gas exchange support
and hemodynamic support is provided by the veno-arterial ECMO system. It
majorly works by passing the blood flow from the patients’ heart and lungs to
the ECMO circuit. The veno-venous ECMO system on the other hand facilitates
sole gas exchange support in which the blood is made to return to the heart
prior to pulmonary circulation. According to the U.S. National Institute of
Health (NIH), combination of veno-venous and veno-arterial is used in specific
cases such as cardiogenic shock.
Applications Insights
As per applications, the
market is segmented into Extracorporeal Cardiopulmonary Resuscitation (ECPR),
respiratory and cardiac. The segments are further segmented on the basis of who
is using the set up into adult application, neonate and pediatric. The segment
dominating the market in 2015 with about 40.0% of the industry share is
respiratory based ECMO.
The increasing demand for
the ECMO systems is majorly attributed to rising number of patients with
chronic respiratory conditions like COPD, emphysema and chronic bronchitis
combined with a trend of growing awareness about health disorders. As per the
U.S. National Center for Health Statistics, more than 8.7 million individuals
suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema
in the year 2014.
Regional Insights
The major regions in this
market are North America, Europe, Asia Pacific, Latin America and MEA. North
America has grown considerably in this segment majorly attributed to the well
developed primary, secondary and tertiary care hospitals combined with the
reimbursement network, increasing awareness about the ECMO system facilitating
their rapid adoption in the hospitals and favorable government funding.
Refinements in the
technology presently in use was made by Terumo Cardiovascular Systems
Corporation during the production of CAPIOX FX Oxygenator. This system is
expected tohelp in increasing the blood rate and offer complete control over
the entire process.
Table of Contents:-
Chapter
1 Methodology and Scope
Chapter
2 Executive Summary
Chapter
3 Extracorporeal Membrane Oxygenation (ECMO): Market Variables, Trends &
Scope
Chapter
4 Extracorporeal Membrane Oxygenation (ECMO): Product Estimates & Trend
Analysis
Chapter
5 Extracorporeal Membrane Oxygenation (ECMO): Application Estimates & Trend
Analysis
Chapter
6 Extracorporeal Membrane Oxygenation (ECMO): End-use Estimates & Trend
Analysis
Chapter
7 Extracorporeal Membrane Oxygenation (ECMO): Industrial End-use Estimates
& Trend Analysis
Chapter
8 Extracorporeal Membrane Oxygenation (ECMO): Regional Estimates & Trend
Analysis
Chapter
9 Competitive Landscape
Chapter
10 Extracorporeal Membrane Oxygenation (ECMO): Manufacturers Company Profiles
Top Key Players of Global Extracorporeal
Membrane Oxygenation (ECMO) Market :
MAQUET Holding B. V. &
Co. KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group,
Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical
Corporation.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment